Short description
Senexis limited operates as a small-molecule drug discovery company, engages in discovering.
Description
Senexis is operates as a small-molecule drug discovery company, engages in discovering compounds for the treatment of ageing-related diseases resulting from the toxicity of amyloid-like proteins. The company offers small molecule inhibitors of amyloid aggregation and toxicity as therapeutic agents to inhibit the pathogenic process of protein misfolding, amyloid-related toxicity, and inflammation.
Total funding
$$121212
Sign in for full access
Location
Manchester, Manchester, United Kingdom, Europe
Founded on
January 1, 2001
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe, Blurry Noaccess
Sign in for full access